News

Jun 24
Press release on the reopening of trading in Aedifica

ANNOUNCEMENT BY THE FINANCIAL SERVICES AND MARKETS AUTHORITY, PUBLISHED IN APPLICATION OF ARTICLE 78 OF THE LAW OF 21 NOVEMBER 2017 Trading in the financial instruments of Aedifica, ISIN BE0003851681 on Euronext Brussels will re-open on 24/06/2022 at 09:00 CET. Source: FSMA

Jun 24
Press release on the suspension of trading in Elia Group

ANNOUNCEMENT BY THE FINANCIAL SERVICES AND MARKETS AUTHORITY, PUBLISHED IN APPLICATION OF ARTICLE 78 OF THE LAW OF 21 NOVEMBER 2017 Trading in the financial instruments of Elia Group, ISIN BE0003822393, on Euronext Brussels is suspended on the request of the company from 24/06/2022 at 09:00 CET until the publication of a press release. Source: […]

Jun 24
Press release on the reopening of trading in Home Invest Belgium

ANNOUNCEMENT BY THE FINANCIAL SERVICES AND MARKETS AUTHORITY, PUBLISHED IN APPLICATION OF ARTICLE 78 OF THE LAW OF 21 NOVEMBER 2017 Trading in the financial instruments of Home Invest Belgium, ISIN BE0974409410 on Euronext Brussels will re-open on 24/06/2022 at 09:00 CET. Source: FSMA

Jun 24
National data-privacy bill passes early test in House

A national data-privacy bill for consumers gained approval from a House subcommittee on Thursday. The bipartisan American Data Privacy and Protection Act next heads to the full Energy and Commerce Committee for a vote, though the legislation is likely to face a tough time there and in the Senate, privacy advocates warn. Rep. Frank Pallone, […]

Jun 24
Chainalysis tips Australia will crack down on misleading crypto ads

Chainalysis’ head of international policy Caroline Malcolm explained this means bringing crypto-assets into a similar regulatory regime to financial products as occurred in the United Kingdom. 1007 Total views 9 Total shares Chainalysis’ head of international policy Caroline Malcolm expects Australia’s new rules governing crypto advertising, promotion and consumer safeguards to follow a similar path […]

Jun 24
Novavax stock surges after COVID-19 vaccine recommended for expanded CMA in the EU for 12-17 year olds

Shares of Novavax Inc. NVAX, +13.92% shot up 9.8% in afternoon trading Thursday, after the biotechnology company said its COVID-19 vaccine Nuvaxovid has been recommended by the Committee for Medicinal Products for Human Use (CHMP) for expanded conditional marketing authorization (CMA) in the European Union for people aged 12 through 17. “This recommendation brings us […]